Primary Target Audience:

Conference is intended for physicians, fellows, residents, nurse practitioners, physician assistants, patient navigators, clinical trial coordinators, and medical students involved in care of patients with complex thoracic disease.

Overall Objective:

1) Identify and/or resolve clinical issues surrounding management of patients with complex thoracic disease; 
2) Develop innovative treatment plans utilizing approved techniques for diagnosis, and treatment; and, 
3) Utilize best disease management practices to reduce morbidity and / or mortality risk.

Faculty/Planning Committee:

Umit Tapan, MD, Course Director, received grant funding from Pfizer for CME activities describing importance of molecular testing in lung cancer, and is Advisory Board Member at Sanofi/Genzyme/Regeneron: has waived the fees.

Gustavo Mercier, MD, Course Co-Director, has no relevant financial relationships to disclose.

Anuradha Saokar Rebello, MD, Planning Committee, has no relevant financial relationships to disclose.

Peter Everett, MD, Planning Committee, has no relevant financial relationships to disclose.

Tina Staffier, Activity Admin, has no relevant financial relationships to disclose.

Sakina Flint, Program Manager, Continuing Medical Education, has no relevant financial relationships to disclose.

Faculty member Gustavo Mercier, MD, does plan on discussing unlabeled/investigational uses of a commercial product: Radiopharmaceuticals for PET/CT, PET/MRi, SPECT/CT that are in Phase III or above trials.

Disclosure Policy:
Boston University School of Medicine asks all individuals involved in the development and presentation of Accredited Continuing Education activities to disclose all financial relationships with ineligible companies. This information is disclosed to all activity participants prior to the start of the educational activity. Boston University School of Medicine has procedures to mitigate all relevant financial relationships with ineligible companies. In addition, faculty members are asked to disclose when any unapproved use of pharmaceuticals and devices is being discussed. In accordance with the Standards for Integrity and Independence in Accredited Continuing Education, all relevant financial relationships with ineligible companies that faculty, planners, authors and anyone who may be in control of content have been mitigated.

Direct Accreditation:

Boston University School of Medicine is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

Boston University School of Medicine designates this live activity for a maximum of 1.00 AMA PRA Category 1 Credit(s)™.  Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Disclaimer:

THESE MATERIALS AND ALL OTHER MATERIALS PROVIDED IN CONJUNCTION WITH CONTINUING MEDICAL EDUCATION ACTIVITIES ARE INTENDED SOLELY FOR PURPOSES OF SUPPLEMENTING CONTINUING MEDICAL EDUCATION PROGRAMS FOR QUALIFIED HEALTH CARE PROFESSIONALS.  ANYONE USING THE MATERIALS ASSUMES FULL RESPONSIBILITY AND ALL RISK FOR THEIR APPROPRIATE USE.  TRUSTEES OF BOSTON UNIVERSITY MAKES NO WARRANTIES OR REPRESENTATIONS WHATSOEVER REGARDING THE ACCURACY, COMPLETENESS, CURRENTNESS, NONINFRINGEMENT, MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE OF THE MATERIALS.  IN NO EVENT WILL TRUSTEES OF BOSTON UNIVERSITY BE LIABLE TO ANYONE FOR ANY DECISION MADE OR ACTION TAKEN IN RELIANCE ON THE MATERIALS.  IN NO EVENT SHOULD THE INFORMATION IN THE MATERIALS BE USED AS A SUBSTITUTE FOR PROFESSIONAL CARE.  IN NO EVENT SHOULD INFORMATION IN THE MATERIALS REGARDING LAWS, REGULATIONS, OR LEGAL LIABILITY BE CONSIDERED LEGAL ADVICE OR USED AS A SUBSTITUTE FOR CONSULTING WITH AN ATTORNEY.

Copyright Notice:

© Trustees of Boston University, 2022